Status: Recruiting
Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome
H syndrome is a rare genetic disorder predisposing to histiocytosis. Our knowledge of the clinical spectrum of these patients is based on case reports and small patient series. Patients with H syndrome have been treated with a range of immunomodulatory and chemotherapeutic agents, with limited success. We aim to comprehensively assess the clinical manifestations and patterns of treatment response in a multinational cohort of patients with H syndrome.
Participants needed: 120
Trial details
Biological sex: AllType: ObservationalSponsor: Rabin Medical CenterUpdated: Dec 19, 2024Locations: 1
Eligibility criteria
Not listed